发明名称 PHENYLACETATE AND DERIVATIVES ALONE OR IN COMBINATION WITH OTHER COMPOUNDS AGAINST NEOPLASTIC CONDITIONS AND OTHER DISORDERS
摘要 Compositions and methods of treating various disorders by administering a therapeutically effective amount of phenylacetate or pharmaceutically acceptable derivatives thereof or derivatives thereof alone or in combination or in conjunction with other therapeu tic agents including retinoids, hydroxyurea, and flavonoids. Intravesicle methods of treatment of cancers phenylacetate. Pharmacologic ally- acceptable salts alone or in combinations and methods of preventing AIDS and malignant conditions, and inducing cell differentiation are also aspects of this invention. A product as a combined preparation of phenylacetate and a retinoid, hydroxyurea, or flavonid (or ot her mevalonate pathway inhibitor) for simultaneous, separate, or sequential use in treating a neoplastic condition in a subject. Methods of modulating lipid metabolism and/or reducing serum triglycerides in a subject using phenylacetate.
申请公布号 CA2173976(C) 申请公布日期 2008.02.19
申请号 CA19942173976 申请日期 1994.10.12
申请人 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SE CRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 发明人 SAMID, DVORIT
分类号 A61K31/203;A61K31/353;A61K;A61K31/035;A61K31/07;A61K31/12;A61K31/17;A61K31/19;A61K31/192;A61K31/20;A61K31/22;A61K31/35;A61K31/365;A61K31/70;A61K31/7072;A61K31/7076;A61K38/21;A61K38/22;A61K45/00;A61K45/06;A61P1/04;A61P3/00;A61P3/06;A61P3/08;A61P3/10;A61P7/00;A61P9/00;A61P13/02;A61P13/08;A61P13/10;A61P13/12;A61P15/00;A61P17/00;A61P17/02;A61P19/02;A61P25/00;A61P27/02;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P35/00;A61P37/02;A61P37/04;A61P37/06;A61P43/00 主分类号 A61K31/203
代理机构 代理人
主权项
地址